Cargando…
In vitro model of perimenopausal depression implicates steroid metabolic and proinflammatory genes
The estimated 20–30% of women who develop perimenopausal depression (PMD) are at an increased risk of cardiovascular and all-cause mortality. The therapeutic benefits of estradiol (E2) and symptom-provoking effects of E2-withdrawal (E2-WD) suggest that a greater sensitivity to changes in E2 at the c...
Autores principales: | Rudzinskas, Sarah, Hoffman, Jessica F., Martinez, Pedro, Rubinow, David R., Schmidt, Peter J., Goldman, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878574/ https://www.ncbi.nlm.nih.gov/pubmed/32788687 http://dx.doi.org/10.1038/s41380-020-00860-x |
Ejemplares similares
-
SUN-197 Differential Gene Expression in Response to Estradiol Withdrawal in Perimenopausal Depression
por: Rudzinskas, Sarah, et al.
Publicado: (2019) -
Divergent Transcriptomic Effects of Allopregnanolone in Postpartum Depression
por: Rudzinskas, Sarah A., et al.
Publicado: (2023) -
Steroid Hormone Secretion Over the Course of the Perimenopause: Findings From the Swiss Perimenopause Study
por: Grub, Jessica, et al.
Publicado: (2021) -
The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with Premenstrual Dysphoric Disorder
por: Dubey, Neelima, et al.
Publicado: (2017) -
Altered estradiol-dependent cellular Ca(2+) homeostasis and endoplasmic reticulum stress response in Premenstrual Dysphoric Disorder
por: Li, Howard J., et al.
Publicado: (2021)